ADCNF (Adicon Holdings) ROC (Joel Greenblatt) %: 3.19% (As of Dec. 2025) — 94% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADCNF Adicon Holdings Ltd ADCNF
75 GF Score
Price $0.65
GF Value $1.19
! 6 Warning Signs
View Full Analysis

What is Adicon Holdings ROC (Joel Greenblatt) %?

Adicon Holdings ADCNF 75 ROC (Joel Greenblatt) % is 3.19% as of Dec. 2025, which is 94% below its 10-year median of 50.93. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.19. The stock has 6 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Adicon Holdings ranks better than 57.82% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Adicon Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 3.19%.

The historical rank and industry rank for Adicon Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

ADCNF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.25   Med: 50.93   Max: 124.62
Current: 4.62

During the past 6 years, Adicon Holdings's highest ROC (Joel Greenblatt) % was 124.62%. The lowest was 4.25%. And the median was 50.93%.

ADCNF's ROC (Joel Greenblatt) % is ranked better than
57.82% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02 vs ADCNF: 4.62

Adicon Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -45.50% per year.


Adicon Holdings  (OTCPK:ADCNF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Adicon Holdings ROC (Joel Greenblatt) % Related Terms


Adicon Holdings ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Adicon Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicon Holdings ROC (Joel Greenblatt) % Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 70.84 124.73 40.14 7.46 4.25

Adicon Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.85 20.57 -1.64 6.50 3.19

ADCNF vs TMO, DHR, IDXX: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, Adicon Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adicon Holdings ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Adicon Holdings's ROC (Joel Greenblatt) % falls into.


ADCNF
75GF Score
Adicon Holdings Ltd ADCNF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicon Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(268.508 + 16.138 + 58.357) - (150.378 + 0 + 21.035)
=171.59

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(241.752 + 18.355 + 180.703) - (159.754 + 0 + 21.156)
=259.9

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Adicon Holdings for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=9.314/( ( (74.626 + max(171.59, 0)) + (78.076 + max(259.9, 0)) )/ 2 )
=9.314/( ( 246.216 + 337.976 )/ 2 )
=9.314/292.096
=3.19 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 3.19% mean?
Adicon Holdings (ADCNF) has a ROC (Joel Greenblatt) % of 3.19% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Adicon Holdings and its competitors. This is 94% below median its historical median of 50.93. Over the past decade, Adicon Holdings' ROC (Joel Greenblatt) % has ranged from 4.25 to 124.62. According to the industry distribution chart, Adicon Holdings ranks #89 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 42.2%.
Is Adicon Holdings' ROC (Joel Greenblatt) % too high?
Adicon Holdings' current ROC (Joel Greenblatt) % of 3.19% is 94% below median its 10-year median of 50.93. Over the past 10 years, this metric has ranged from a low of 4.25 to a high of 124.62. Based on the distribution chart, Adicon Holdings ranks #89 out of 211 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' ROC (Joel Greenblatt) % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #89 out of 211 companies for ROC (Joel Greenblatt) %. This puts Adicon Holdings in the upper half of its industry. Historically, Adicon Holdings' own ROC (Joel Greenblatt) % has ranged from 4.25 to 124.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Adicon Holdings and its competitors. Adicon Holdings's current ROC (Joel Greenblatt) % is 3.19%, which is 94% below median its own 10-year median of 50.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current ROC (Joel Greenblatt) % of 3.19%. The stock's GF Value™ is $1.19, compared to a current price of $0.65 — trading 45.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 3.19%, which is 94% below median its 10-year median of 50.93. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current ROC (Joel Greenblatt) % is 3.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adicon Holdings (ADCNF) Overvalued in 2026?

Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued. The current stock price of $0.65 is trading 45.4% below its estimated GF Value™ of $1.19.

Key valuation signals for ADCNF:

  • ROC (Joel Greenblatt) %: 3.19% (94% below median its 10-year median of 50.93)
  • GF Value™: $1.19 vs. price of $0.65 (45.4% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adicon Holdings Business Description

Other Exchanges 09860:Hong Kong
Address No. 208, Zhenzhong Road, West Lake District, Xihu District, Hangzhou, CHN
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score

Get the complete analysis for ADCNF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$1.19
GF Value